The Latin America, Middle East and Africa Cell Viability Assays Market should witness market growth of 15.5% CAGR during the forecast period (2022-2028).
ATP (Adenosine triphosphate) cell viability is an assay used to measure cell viability since only viable cells can make ATP. Reagents with the CellTiter-Glo luminescent cell viability assay that contains detergent, luciferin substrate, and stabilized luciferase can be used to measure ATP. The detergent lyses viable cells, discharging ATP into the medium.
Luciferin is used by luciferase to create luminescence in the presence of ATP, which can be detected in a few minutes using a luminometer. The CellTiter-Glo 2.0 Assay is given as a single solution that decreases the reagent preparation time and allows storing it at room temperature, making implementation easier.
As these ATP assays don’t require lengthy incubation times to convert a substrate into a colored product, they usually work faster than other methods. In addition, they have wide linearity and excellent sensitivity, making them very suitable for high throughput applications with low cell numbers. They also have reduced risks of artifacts than other methods.
The Dubai Health Authority (DHA), a governing entity, is responsible for monitoring the Health System in the Emirates of Dubai. DHA was established in 2007 by the Prime Minister of Dubai. The Health Regulation Sector (HRS) of the DHA is responsible for licensing, monitoring, and regulating health facilities and the professionals related to healthcare.
The Brazil market dominated the LAMEA Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $58.2 million by 2028. The Argentina market is experiencing a CAGR of 16.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 15.2% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
ATP (Adenosine triphosphate) cell viability is an assay used to measure cell viability since only viable cells can make ATP. Reagents with the CellTiter-Glo luminescent cell viability assay that contains detergent, luciferin substrate, and stabilized luciferase can be used to measure ATP. The detergent lyses viable cells, discharging ATP into the medium.
Luciferin is used by luciferase to create luminescence in the presence of ATP, which can be detected in a few minutes using a luminometer. The CellTiter-Glo 2.0 Assay is given as a single solution that decreases the reagent preparation time and allows storing it at room temperature, making implementation easier.
As these ATP assays don’t require lengthy incubation times to convert a substrate into a colored product, they usually work faster than other methods. In addition, they have wide linearity and excellent sensitivity, making them very suitable for high throughput applications with low cell numbers. They also have reduced risks of artifacts than other methods.
The Dubai Health Authority (DHA), a governing entity, is responsible for monitoring the Health System in the Emirates of Dubai. DHA was established in 2007 by the Prime Minister of Dubai. The Health Regulation Sector (HRS) of the DHA is responsible for licensing, monitoring, and regulating health facilities and the professionals related to healthcare.
The Brazil market dominated the LAMEA Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $58.2 million by 2028. The Argentina market is experiencing a CAGR of 16.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 15.2% during (2022-2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
Scope of the Study
By Product
- Consumables
- Reagents & Assay Kits
- Luminometric Assays
- Dye Exclusion Assays
- Colorimetric Assays
- Fluorometric Assays
- Microplates
- Reagents & Assay Kits
- Instruments
- Spectrophotometer
- Microscopy
- Cell Imaging & Analysis System
- Flow Cytometry
- Others
By End-user
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Diagnostic Labs
By Application
- Stem Cell Research
- Drug Discovery & Development
- Diagnostics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cell Viability Assays Market, by Product
1.4.2 LAMEA Cell Viability Assays Market, by End User
1.4.3 LAMEA Cell Viability Assays Market, by Application
1.4.4 LAMEA Cell Viability Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Cell Viability Assays Market by Product
4.1 LAMEA Consumables Market by Country
4.2 LAMEA Cell Viability Assays Market by Consumables Type
4.2.1 LAMEA Reagents & Assay Kits Market by Country
4.2.2 LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type
4.2.2.1 LAMEA Luminometric Assays Market by Country
4.2.2.2 LAMEA Dye Exclusion Assays Market by Country
4.2.2.3 LAMEA Colorimetric Assays Market by Country
4.2.2.4 LAMEA Fluorometric Assays Market by Country
4.2.3 LAMEA Microplates Market by Country
4.3 LAMEA Instruments Market by Country
4.4 LAMEA Cell Viability Assays Market by Instruments Type
4.4.1 LAMEA Spectrophotometer Market by Country
4.4.2 LAMEA Microscopy Market by Country
4.4.3 LAMEA Cell Imaging & Analysis System Market by Country
4.4.4 LAMEA Flow Cytometry Market by Country
4.4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Cell Viability Assays Market by End-user
5.1 LAMEA Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 LAMEA CROs & CMOs Market by Country
5.3 LAMEA Academic & Research Institutes Market by Country
5.4 LAMEA Diagnostic Labs Market by Country
Chapter 6. LAMEA Cell Viability Assays Market by Application
6.1 LAMEA Stem Cell Research Market by Country
6.2 LAMEA Drug Discovery & Development Market by Country
6.3 LAMEA Diagnostics Market by Country
Chapter 7. LAMEA Cell Viability Assays Market by Country
7.1 Brazil Cell Viability Assays Market
7.1.1 Brazil Cell Viability Assays Market by Product
7.1.1.1 Brazil Cell Viability Assays Market by Consumables Type
7.1.1.1.1 Brazil Cell Viability Assays Market by Reagents & Assay Kits Type
7.1.1.2 Brazil Cell Viability Assays Market by Instruments Type
7.1.2 Brazil Cell Viability Assays Market by End-user
7.1.3 Brazil Cell Viability Assays Market by Application
7.2 Argentina Cell Viability Assays Market
7.2.1 Argentina Cell Viability Assays Market by Product
7.2.1.1 Argentina Cell Viability Assays Market by Consumables Type
7.2.1.1.1 Argentina Cell Viability Assays Market by Reagents & Assay Kits Type
7.2.1.2 Argentina Cell Viability Assays Market by Instruments Type
7.2.2 Argentina Cell Viability Assays Market by End-user
7.2.3 Argentina Cell Viability Assays Market by Application
7.3 UAE Cell Viability Assays Market
7.3.1 UAE Cell Viability Assays Market by Product
7.3.1.1 UAE Cell Viability Assays Market by Consumables Type
7.3.1.1.1 UAE Cell Viability Assays Market by Reagents & Assay Kits Type
7.3.1.2 UAE Cell Viability Assays Market by Instruments Type
7.3.2 UAE Cell Viability Assays Market by End-user
7.3.3 UAE Cell Viability Assays Market by Application
7.4 Saudi Arabia Cell Viability Assays Market
7.4.1 Saudi Arabia Cell Viability Assays Market by Product
7.4.1.1 Saudi Arabia Cell Viability Assays Market by Consumables Type
7.4.1.1.1 Saudi Arabia Cell Viability Assays Market by Reagents & Assay Kits Type
7.4.1.2 Saudi Arabia Cell Viability Assays Market by Instruments Type
7.4.2 Saudi Arabia Cell Viability Assays Market by End-user
7.4.3 Saudi Arabia Cell Viability Assays Market by Application
7.5 South Africa Cell Viability Assays Market
7.5.1 South Africa Cell Viability Assays Market by Product
7.5.1.1 South Africa Cell Viability Assays Market by Consumables Type
7.5.1.1.1 South Africa Cell Viability Assays Market by Reagents & Assay Kits Type
7.5.1.2 South Africa Cell Viability Assays Market by Instruments Type
7.5.2 South Africa Cell Viability Assays Market by End-user
7.5.3 South Africa Cell Viability Assays Market by Application
7.6 Nigeria Cell Viability Assays Market
7.6.1 Nigeria Cell Viability Assays Market by Product
7.6.1.1 Nigeria Cell Viability Assays Market by Consumables Type
7.6.1.1.1 Nigeria Cell Viability Assays Market by Reagents & Assay Kits Type
7.6.1.2 Nigeria Cell Viability Assays Market by Instruments Type
7.6.2 Nigeria Cell Viability Assays Market by End-user
7.6.3 Nigeria Cell Viability Assays Market by Application
7.7 Rest of LAMEA Cell Viability Assays Market
7.7.1 Rest of LAMEA Cell Viability Assays Market by Product
7.7.1.1 Rest of LAMEA Cell Viability Assays Market by Consumables Type
7.7.1.1.1 Rest of LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type
7.7.1.2 Rest of LAMEA Cell Viability Assays Market by Instruments Type
7.7.2 Rest of LAMEA Cell Viability Assays Market by End-user
7.7.3 Rest of LAMEA Cell Viability Assays Market by Application
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Abcam plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. Biotium, Inc.
8.10.1 Company Overview
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Becton, Dickinson and Company
- PerkinElmer Inc.
- Promega Corporation
- Biotium
- Creative Bioarray
- Abcam Plc
